Drugs

Open Access
Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study
Carole E. Aubert, Manuel R. Blum, Viktoria Gastens, Olivia Dalleur, Fanny Vaillant, Emma Jennings, Drahomir Aujesky, Wade Thompson, Tijn Kool, Cornelius Kramers, Wilma Knol, Denis O’Mahony and Nicolas Rodondi

February 28, 2023 11 (1) E170-E178; DOI: https://doi.org/10.9778/cmajo.20210240
Open Access
Hospital discharges for substance-related injuries before and during the COVID-19 pandemic: a descriptive surveillance study using administrative data
Stephanie Toigo, Steven R. McFaull and Wendy Thompson

January 24, 2023 11 (1) E54-E61; DOI: https://doi.org/10.9778/cmajo.20220164
Open Access
Universal ophthalmia neonatorum prophylaxis in Ontario: a cost-effectiveness analysis
Ellen C. Rowlands Snyder, Elspeth McGregor and Doug Coyle

January 17, 2023 11 (1) E33-E39; DOI: https://doi.org/10.9778/cmajo.20210226
Open Access
The impact of the Choosing Wisely Canada campaign on the simultaneous use of angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers: interrupted time-series analysis
Tracey-Lea Laba, Heather C. Worthington, Lucy Cheng, Fiona K.I. Chan, Nick Bansback and Michael R. Law

December 13, 2022 10 (4) E1059-E1066; DOI: https://doi.org/10.9778/cmajo.20210185
Open Access
Time to potential for listing of new drugs on public and private formularies in Canada: a cross-sectional study
Joel Lexchin

November 15, 2022 10 (4) E993-E999; DOI: https://doi.org/10.9778/cmajo.20220063
Open Access
Secondary causes of elevated hemoglobin in patients undergoing molecular testing for suspected polycythemia vera in southwestern Ontario: a chart review
Benjamin Chin-Yee, Maxim Matyashin, Ian Cheong, Pratibha Bhai, Alejandro Lazo-Langner, Ala Almanaseer, Eri Kawata, Michael A. Levy, Alan Stuart, Hanxin Lin, Ian Chin-Yee, Bekim Sadikovic and Cyrus Hsia

November 08, 2022 10 (4) E988-E992; DOI: https://doi.org/10.9778/cmajo.20210322
Open Access
Chronic diseases and variations in rates of antimicrobial use in the community: a population-based analysis of linked administrative data in Quebec, Canada, 2002–2017
Élise Fortin, Caroline Sirois, Caroline Quach, Sonia Jean, Marc Simard, Marc Dionne, Alejandra Irace-Cima and Nadine Magali-Ufitinema

September 27, 2022 10 (3) E831-E840; DOI: https://doi.org/10.9778/cmajo.20210258
Open Access
Chronic diseases and compliance with provincial guidelines for outpatient antibiotic prescription in cases of otitis media and respiratory infections: a population-based study of linked data in Quebec, Canada, 2010–2017
Élise Fortin, Geneviève Deceuninck, Caroline Sirois, Caroline Quach, Marc Simard, Marc Dionne, Sonia Jean, Alejandra Irace-Cima and Nadine Magali-Ufitinema

September 27, 2022 10 (3) E841-E847; DOI: https://doi.org/10.9778/cmajo.20210257
Open Access
Abortion services and providers in Canada in 2019: results of a national survey
Regina M. Renner, Madeleine Ennis, Damien Contandriopoulos, Edith Guilbert, Sheila Dunn, Janusz Kaczorowski, Elizabeth K. Darling, Arianne Albert, Claire Styffe and Wendy V. Norman

September 27, 2022 10 (3) E856-E864; DOI: https://doi.org/10.9778/cmajo.20210232
Open Access
Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trial
Vincent I. Lau, Robert Fowler, Ruxandra Pinto, Alain Tremblay, Sergio Borgia, François M. Carrier, Matthew P. Cheng, John Conly, Cecilia T. Costiniuk, Peter Daley, Erick Duan, Madeleine Durand, Patricia S. Fontela, George Farjou, Mike Fralick, Anna Geagea, Jennifer Grant, Yoav Keynan, Kosar Khwaja, Nelson Lee, Todd C. Lee, Rachel Lim, Conar R. O’Neil, Jesse Papenburg, Makeda Semret, Michael Silverman, Wendy Sligl, Ranjani Somayaji, Darrell H.S. Tan, Jennifer L.Y. Tsang, Jason Weatherald, Cedric Philippe Yansouni, Ryan Zarychanski and Srinivas Murthy; for the E-CATCO authors, AMMI Clinical Research Network and Canadian Critical Care Trials Group

September 06, 2022 10 (3) E807-E817; DOI: https://doi.org/10.9778/cmajo.20220077

Main menu

User menu

Search

Drugs

Pages

Content

Authors & Reviewers

About